www.fgks.org   »   [go: up one dir, main page]


Publication Information
Available Issues

Diabetes Care


Featured in This Issue:
Age of Onset Influences Long-Term Retinopathy Risk in Type 2 Diabetes... Benefits of Insulin on Glycemic Control in Type 2 Diabetes...


Available Content
2008
DOTS
Age of Onset Influences Long-Term Retinopathy Risk in Type 2 Diabetes... Benefits of Insulin on Glycemic Control in Type 2 Diabetes...
DOTS

The Missed Patient With Diabetes... Two-Year Pulmonary Safety and Efficacy of Inhaled Human Insulin...
DOTS

Prevalence of Diabetes in the Multi-Ethnic Study of Atherosclerosis ... Monitoring Quality of Life in Adolescents With Type 1 Diabetes ...
DOTS

Dietary Behaviors Predict Glycemic Control in Youth... Intake of Fruit, Vegetables, and Risk of Diabetes in Women...
DOTS

Improving Depression Outcomes in Patients With Depression and Diabetes... A Community-Based Diabetes Prevention Program in a Rural India...
DOTS

Medication Adherence and Racial Differences in A1C Control... Rosiglitazone-Associated Fractures in Type 2 Diabetes...
DOTS

Bone Fractures and Hypoglycemic Treatment in Type 2 Diabetic Patients... Evaluation of a System for Automatic Detection of Diabetic Retinopathy ...
DOTS

DDP-4 Vildagliptin Improves Beta-Cell Function... Effect of Cinnamon on Glucose Control and Lipid Parameters...
DOTS

2007
DOTS
Does Waist Circumference Predict Diabetes and CVD Risk?... Recruitment to a Clinical Trial Improves Glycemic Control...
DOTS

Missing the Point: Substituting Exenatide for Nonoptimized Insulin... Long-Term Predictors of Insulin Resistance... Exploring the Substitution of Exenatide for Insulin in Type 2 Diabetes...
DOTS

Patient Perceptions of Quality of Life With Diabetes-Related Complications ... Type 2 Diabetes Prevention in the "Real World"...
DOTS

American Diabetes Association Statement on Emergency, Disaster Preparedness... Consensus Statement on Standardization of the Hemoglobin A1C Measurement...
DOTS

Clinical Factors Associated With Resistance to Microvascular Complications... Effect of Initial Combination Therapy With Sitagliptin and Metformin...
DOTS

Prospective Study of Type 1 and Type 2 Diabetes and Risk of Stroke Subtypes... Consequences of Change in Waist Circumference...
DOTS

Dipeptidyl Peptidase-4 Inhibitors: Clinical Data and Clinical Implications... Dipeptidyl Peptidase-4 Inhibition and the Treatment of Type 2 Diabetes...
DOTS

Risk Equations Do Not Provide Reliable Cardiovascular Risk Estimates... Cardiac Imaging for Risk Stratification in Diabetes...
DOTS

Effects of Vildagliptin on Glucose Control Over 24 Weeks in Type 2 Diabetes... Patient Medication Adherence and Clinical Inertia in Type 2 Diabetes...
DOTS

Impaired Fasting Glucose and Impaired Glucose Tolerance...
DOTS

Primary Prevention of Cardiovascular Diseases in People With Diabetes... Definitions of the Metabolic Syndrome as Predictors of Diabetes...
DOTS

2006
DOTS
Two-Year Safety and Efficacy of Inhaled Human Insulin in Adult Diabetics...
DOTS

Progression From Newly Acquired Impaired Fasting Glucose to Type 2 Diabetes... Vildagliptin and Rosiglitazone Monotherapy in Patients with Type 2 Diabetes...
DOTS

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin... Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy...
DOTS

Comparison of Glargine Insulin Versus Rosiglitazone Addition... Long-Term Efficacy of Metformin Therapy in Nonobese Individuals...
DOTS

Efficacy and Safety of Angiotensin II Receptor Blockade in Elderly Patients... A Double-Blind, Placebo-Controlled Trial Assessing Pramlintide Treatment...
DOTS

Disparities in HbA1c Levels Between African-American and Non-Hispanic White... Predictors and Outcomes in the Diabetes Prevention Program...
DOTS

Management of Hyperglycemia in Type 2 Diabetes... Effectiveness of First and Repeat Influenza Vaccination in Diabetics...
DOTS

The Metabolic Syndrome (Emperor) Wears No Clothes... Does the Metabolic Syndrome Exist?...
DOTS

Comparing Insulin Detemir With NPH Insulin as Add-On Therapy... The Treating to New Targets (TNT) Study ...
DOTS

Diet of Adolescents With and Without Diabetes ... Improvement of Glycemic Control &Triglycerides With Muraglitazar...
DOTS

Novel Once-Daily Extended-Release Metformin ... Pancreas and Islet Transplantation in Type 1 Diabetes ...
DOTS

Health Care Professionals Advising Diabetic Patients to Exercise... Prevalence of the Metabolic Syndrome & CVD Incidence...
DOTS

Presence of Diabetes Risk Factors - Large U.S. 8th Grade Cohort... Mimicking the Effects of Amylin and Glucagon-Like Peptide 1...
DOTS

A Single Factor Underlies the Metabolic Syndrome... The Fidgety Fetus Hypothesis...
DOTS

2005
DOTS
Insulin Resistance Atherosclerosis Study... Results and Clinical Implications of the PROactive Study ...
DOTS

Resistance to Insulin Therapy Among Patients and Providers... Association of Comorbid Depression With Mortality in Diabetes...
DOTS

Clinical Outcomes - Metformin in Patients With Diabetes & HF... Improving Primary Care of African Americans with Diabetes...
DOTS

PRESERVE-Beta - Efficacy and Safety ... The Metabolic Syndrome: Time for a Critical Appraisal...
DOTS

Foot Ulcer Risk - South-Asian, African-Caribbean, and UK ... Vildagliptin and Improved Beta-Cell Function...
DOTS

Inhaled Insulin Basal/Bolus Insulin Regimen in Type 1 Diabetes... Comparison: Pioglitazone and Rosiglitazone in Type 2 Diabetes...
DOTS

Combination of Weight Loss Therapies for Type 2 Diabetes...
DOTS

Exenatide Effects on Glycemic Control in Type 2 Diabetes...
DOTS

Diabetic Neuropathies: A Statement by the ADA... The Metabolic Syndrome & Concentrations of C-Reactive Protein...
DOTS

Sex Disparities - Cardiac Risk Factors in Type 2 Diabetes... Drug Therapy to Delay or Prevent Type 2 Diabetes...
DOTS

Stress May Induce Diabetes-Related Autoimmunity in Infancy... Metabolic Syndrome & 11-Year Risk of Incident CVD...
DOTS

Care of Children and Adolescents With Type 1 Diabetes ... Diabetic Nephropathy: Diagnosis, Prevention, and Treatment ...
DOTS

2004
DOTS
12 & 52 Week Efficacy of Dipeptidyl PeptidaseIV Inhibitor LAF237... Walnuts in Diet Improves HDL Cholesterol-Total Cholesterol Ratio...
DOTS

Effects of Exenatide (Exendin-4) on Glycemic Control ... Efficacy & Safety of Inhaled Insulin in Type 1 Diabetics...
DOTS

Increasing Prevalence of Metabolic Syndrome Among U.S. Adults... Safety & Efficacy of Inhaled Insulin vs. Subcutaneous Insulin...
DOTS

Red Meat and Type 2 Diabetes in Women... Metabolic Syndrome in Normal-Weight Americans ...
DOTS

Additive Effects of GLP-1 and Pioglitazone... Weight Management Using Lifestyle Modification...
DOTS

Relationship Between Adiponectin and Glycemic Control in Men... Comparison of CSII and glargine-based MDI therapy in youth...
DOTS

Patient Satisfaction and Glycemic Control After 1 Year... Improved Glycemic Control With No Weight Increase in Patients...
DOTS

Orlistat Augments Postprandial Increases in Glucagon-like... Global Prevalence of Diabetes: Estimates for the Year 2000...
DOTS

C-Reactive Protein and Incident Cardiovascular Events Among Men... Critical Evaluation of Adult Treatment Panel III Criteria...
DOTS

Effect of Diabetes Duration on Coronary Heart Disease Mortality... Predictors of the Incident Metabolic Syndrome in Adults...
DOTS

Cardiac Abnormalities in Diabetic Patients With Neuropathy... Literacy and Pregnancy Preparedness in Pregestational Diabetes...
DOTS

Type 2 Diabetes Prevalence in Asian Americans... Effects of Weight Loss and Orlistat on Type 2 Diabetes...
DOTS

2003
DOTS
The Finnish Diabetes Prevention Study - DPS... Peripheral Arterial Disease in People With Diabetes...
DOTS

Effective Exercise Modality to Reduce Insulin Resistance... Insulin Detemir Is Characterized by a Consistent Pharmacokinetic...
DOTS

Subcutaneous Administration of Glucagon-Like Peptide 1... Results From the LIPID Trial ...
DOTS

Type 2 Diabetes Randomized, Parallel-Group, 24-Week Study... Lifestyle Intervention or Metformin for Prevention of Diabetes...
DOTS

Effect on Glycemic Control of Exenatide... Effects of Adding Angiotensin II Receptor Blocker to ACE...
DOTS

Management of Dyslipidemia in Diabetic Children and Adolescents ... Vascular Risk Factors and Markers of Endothelial Function...
DOTS

Addition of Nateglinide to Rosiglitazone Monotherapy... Type 2 Diabetes and Subsequent Incidence of Breast Cancer...
DOTS

Insulin Resistance-Related Factors Predict Coonary Artery Dis.... Importance of Insulin Secretion and Resistance...
DOTS

Insulin Pump Therapy... Safety and Effectiveness of Insulin Pump Therapy in Children ...
DOTS

Postheparin Plasma Lipase Activity in Previously Sedentary Adult... Economic Costs of Diabetes in the U.S. in 2002 ...
DOTS

Aging Per Se Does Not Influence Glucose Homeostasis... Acarbose Improves Glycemic Control in Overweight Type 2 Diabetic...
DOTS

Position Statement: Diabetic Retinopathy ... Non-HDL Cholesterol as a Predictor of Cardiovascular Disease ...
DOTS

2002
DOTS
Nateglinide ... The Diabetes Prevention Program (DPP)...
DOTS

Irbesartan Reduces the Albumin Excretion Rate ... Vitamin E and High-Risk Patients With Diabetes...
DOTS

What We Think and What We Know... Hormone Replacement Therapy and Lipid and Glucose Metabolism...
DOTS

Influence of Health Care Providers on Diabetes Development... Diabetes Contributes to Cholesterol Metabolism ...
DOTS

Weight Control Practices and Adolescents With Type 1 Diabetes... Comparison of the Effects of Three Insulinotropic Drugs on Plasm...
DOTS

Cardiovascular Disease Risk Prior to Diagnosis of Diabetes... Dietary Gluten and Type 1 Diabetes...
DOTS

Longitudinal Association of Glycemia and Microalbuminuria ... Oral Contraceptive Use and Diabetes ...
DOTS

Evaluation of Liver Function in Type 2 Diabetic Patients... A Controlled Evaluation of Staging Dietary Patterns...
DOTS

Diabetes Disease Management... The Prevention or Delay of Type 2 Diabetes...
DOTS

Intensive Lifestyle Changes... Continuous Subcutaneous Insulin Infusion...
DOTS

Health Outcomes of Severely Obese Type 2 Diabetic Subjects... Relationship Between Plasma Glucose and HbA1c...
DOTS

The Treatment of Hypertension in Adult Patients With Diabetes ... Effect of Metformin in Pediatric Patients With Type 2 Diabetes...
DOTS

2001
DOTS
Rapid Progression of Albumin Excretion... Reduced Cardiovascular Morbidity and Mortality...
DOTS

Remission of Nephrotic-range Albuminuria in Type 1 Diabetic Patients... Limitations of Conventional Methods of Self-monitoring...
DOTS

Intensive Insulin Therapy With Insulin Lispro... Influence of Intensive Diabetes Treatment on Body Weight...
DOTS

Clinical and Psychological Course of Diabetes... Neuropsychological Profiles of Children With Type 1 Diabetes...
DOTS

Third-Trimester Maternal Glucose Levels... Evaluation of the Insulin Resistance Syndrome...
DOTS

Diabetic Pregnancy... Gestational Diabetes Mellitus...
DOTS

The Prevalence of Comorbid Depression in Adults With Diabetes: a...... Frequency of Blood Glucose Monitoring in Relation to Glycemic Control......
DOTS

Detection of Hypoglycemia With the GlucoWatch Biographer... The Third National Health and Nutrition Examination Survey...
DOTS

Glucose Intolerance... Cardiovascular Morbidity and Mortality...
DOTS

Behavior Therapy for Families of Adolescents With Diabetes... Retinopathy in Subjects With Type 1 Diabetes...
DOTS

Aspirin Use Among Adults With Diabetes: Estimates from the Third...... Increased Prevalence of Significant Coronary Artery Calcification...
DOTS

Management of Hyperglycemic Crises in Patients With Diabetes... Diastolic Dysfunction in Normotensive Men With Well-Controlled Type 2......
DOTS

... Management of Dyslipidemia in Adults With Diabetes...
DOTS

2000
DOTS
Risk of Type 1 Diabetes in Children... Postchallenge Plasma Glucose...
DOTS

Linking Pharmacy and Laboratory Data... Appropriate Insulin Regimes for Type 2 Diabete...
DOTS

Incidence of Childhood Type 1 Diabetes Worldwide... Screening for Type 2 Diabetes...
DOTS

Therapy Focused on Lowering Postprandial Glucose... Secular Trends in Birth Weight...
DOTS

Effect of Pregnancy on Microvascular Complications... Studies With a Covalently Linked Thyroxyl-Insulin Complex in Humans...
DOTS

Therapeutic Benefits of ACE Inhibitors in Patients With Type 2 Diabetes... Differences in the Performance of Commercially Available 10-g......
DOTS

Is There a Glycemic Threshold for Impaired Autonomic Control?... Asymptomatic Bacteriuria as a Complication of Diabetes...
DOTS

Consequences of a Family History of Type 1 and Type 2... Less Hypoglycemia With Insulin...
DOTS

Cross-Cultural Activity Participation Study... Visceral Adiposity and Risk of Type 2 Diabetes...
DOTS

ADA Consensus Statement... Enalapril Prevents Clinical Proteinuria...
DOTS

Mealtime Insulin Secretion With Nateglinide Controls... Insulin Resistance and Quantification of Insulin-Mediated Glucose......
DOTS

Impaired Fasting Glucose: How Low Should It Go?... Mortality Risks and Reproducibility for Glucose Tolerance Categories...
DOTS

Diagnosis and Classification of Diabetes Mellitus... Standards of Medical Care for Patients With Diabetes Mellitus... Immunization and the Prevention of Influenza and Pneumococcal Disease...
DOTS

1999
DOTS
Eating Habits, Body Weight, and Insulin Misuse... Liver Disease in Type 2 Diabetic Patients...
DOTS

Effect of Simvastatin Treatment... Continuous Subcutaneous Insulin Infusion...
DOTS

Fast-Acting Insulin Analog Lispro on Nocturnal Hypoglycemia... Perinatal Risk Factors for Childhood Type 1 Diabetes in Europe...
DOTS

Silent Myocardial Ischemia in Patients With Diabetes... Perioperative Glycemic Control and Risk Infection in Diabetes...
DOTS

Conventional Versus Intensive Diabetes Therapy in Children... Improved Postprandial Glycemic Control...
DOTS

Fasting Insulin, Body Fat Distribution, and Diabetes...
DOTS

Impaired Glucose Tolerance Is Factor in Cardiovascular Disease... 14-Year Incidence of Lower-Extremity Amputations in Diabetics...
DOTS

Bone Mineral Density... Parent-Adolescent Teamwork in Diabetes Management... Dyslipidemic Phenotypes Associated With Cardiovascular Risk...
DOTS

Discrepancies in the Use of the Semmes-Weinstein Monofilament... Insulin Sensitivity in Subjects With Type 2 Diabetes...
DOTS

Differences in Glycemic Control of Adults With Type 2 Diabetes... Natural History of Diabetic Gastroparesis...
DOTS

Relationship Between Glucose and Incident Cardiovascular Events... Effects of a Thiazolidinedione Compound on Type 2 Diabetes...
DOTS

Improved Glycemic Control in Type 2 Diabetic Patients... Effect of Repaglinide Addition on Patients With Type 2 Diabetes...
DOTS

Management of Dyslipidemia in Adults With Diabetes... Implications of the Diabetes Control and Complications Trial... Report on the Diagnosis and Classification of Diabetes Mellitus... Standards of Medical Care for Patients With Diabetes Mellitus... Hospital Admission Guidelines for Diabetes Mellitus...
DOTS

1998
DOTS
Endothelium-Dependent Vasodilatation With Gestational Diabetes... 1998 Presidential Address - Diabetes Research and Diabetes Care...
DOTS

Placebo-Controlled Trial of Repaglinide for Diabetes... Gestational Diabetes: Testing Lean Young Caucasian Women...
DOTS

Diabetic Retinopathy...
DOTS

Back to Top


Related Resources
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.